Related references
Note: Only part of the references are listed.Biochemical and biopharmaceutical properties of PEGylated uricase
Debora da Silva Freitas et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: A comparison with glycosylated erythropoietin
Yin-Jue Wang et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Severe congenital neutropenia and pegfilgrastim
Paivi M. Lahteenmaki et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor
Ingmar Bruns et al.
HAEMATOLOGICA (2008)
Comparison of bioactivities of monopegylated rhG-CSF with branched and linear mPEG
Xing-Qi Li et al.
PROCESS BIOCHEMISTRY (2007)
Novel treatment for severe congenital neutropenia with pegfilgrastim
L. Mi Rim Choi et al.
BLOOD (2007)
G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms
Marta Donini et al.
BLOOD (2007)
Modulation of protein aggregation by polyethylene glycol conjugation: GCSF as a case study
RS Rajan et al.
PROTEIN SCIENCE (2006)
Congenital neutropenia: advances in diagnosis and treatment
Raffaele Badolato et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2004)
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
MD Green et al.
ANNALS OF ONCOLOGY (2003)
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer
FA Holmes et al.
ANNALS OF ONCOLOGY (2002)
Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia
T Lehrnbecher
KLINISCHE PADIATRIE (2001)
Severe chronic neutropenia in Chinese children in Hong Kong
TF Leung et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2001)
Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen to disease type 1b
S Calderwood et al.
BLOOD (2001)
Severe congenital neuropenia: Diagnosis and therapy
C Zeidler et al.
KLINISCHE PADIATRIE (2000)
Complication of rapidly progressive glomerulonephritis in severe congenital neutropenia treated with long-term granulocyte colony-stimulating factor (filgrastim)
M Sotomatsu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
